Engineering the building blocks for smarter RNA therapies

We are redefining nucleoside synthesis, applying principles from small molecule drug discovery to develop scalable, precisely tailored nucleosides that will transform the oligo field. By expanding the chemical toolkit to unprecedented extents, we will enable smarter RNA therapies to address critical unmet needs, improve outcomes, and make a meaningful impact on patients’ lives.